SRS Implant - Anchorless Single-Incision System
The SRS Implant enables revolutionary surgical treatment of women with anterior prolapse with or without involvement of the apical compartment. Self-Retaining Support (SRS) technology eliminates the need for anchorage or fixation systems.
Please note, that this product is currently only available in certain markets. Please contact us to find out details about your country.
Improves Quality of Life Levy et al. showed a significant improvement in quality of life in the long-term follow-up of the SRS-I and SRS-II trial.1
Simple and fast The preparation of the paravaginal space is similar to that of other transvaginal meshes. For the experienced surgeon the operation is therefore easy to perform. The mean operative time in the SRS-II trial was 24.7 minutes.1
Proven safety No intraoperative complications occurred in the SRS-I and SRS-II trial. No mesh erosion or chronic pain was documented during the entire follow-up.1
Anatomically excellent reconstruction After a median follow-up of 38.4 months, 60/70 patients (85.7%) had a POP-Q stage 0 and 6/70 patients (8.6%) had a POP-Q stage 1.1
- Material: Titanised type 1a polypropylene mesh
- Macroporous: 1 mm pore size
- Ultra-light: 16 g/m²
- Monofilament knitted fabrics
- Non-absorbable: conscious renunciation of resorbable portion
- Material: The frame of the SRS Implant consists of the high- performance polymer polyetheretherketone (PEEK). PEEK is an attractive alternative to titanium because of its lower weight, strength and biocompatibility. PEEK is being widely used for orthopedics and dental implants.
The SRS Implant is intended for the treatment of anterior vaginal wall prolapse with/without apex/uterine prolapse. The SRS Implant is indicated for use in adult females (> 21 years) suffering from anterior vaginal wall prolapse POP-Q ≥ stage 2 (point Ba > -1 cm).
Lyra Medical Ltd.
Binyamina, Israel 3057324
1 Levy et al., Surgical treatment of advanced anterior wall and apical vaginal prolapse using the anchorless self-retaining support implant: long-term follow-up, Int Urogynecol J. 2022, 13: 1-9